Table 1 Comparison of systemic features amongst cases and controls
Cases (33 patients) | Controls (21 patients) | P value | |
|---|---|---|---|
Age (years) | 56.6+/-6,78 | 58.4 +/-7.84 | 0.375 |
Gender n (%) | |||
Males | 28 (84.8%) | 14 (66.7%) | |
Females | 5 (15.2%) | 7 (33.3%) | |
Duration of diabetes (years) | 9.45 +/- 6.08 | 9.7 +/-5.12 | 0.876 |
Systemic associations n (%) | |||
Hypertension | 24 (72.7%) | 14 (66.7%) | 0.634 |
Hyperlipidemia | 3 (9.1%) | 1 (4.8%) | 1.000 |
Nephropathy | 1 (3%) | 0 | 1.000 |
S/p CABG | 1 (3%) | 0 | 1.000 |
Systemic medications n (%) | |||
Antidiabetic insulin | 3 (9.1%) | 3 (14.3%) | 0.667 |
Group 1 (biguanides) | 7 (21.2%) | 9 (42.9%) | 0.089 |
Group 2 (glitazones) | 5 (15.2%) | 1 (4.8%) | 0.386 |
Group 3 (sulfonylureas) | 22 (66.7%) | 14 (66.7%) | 1.000 |
Antihypertensive | 18 (54.6%) | 10 (47.6%) | 0.619 |
Mean value of systemic parameters | |||
HbA 1c | 6.73 +/- 1.42 | 6.71 +/- 1.39 | 0.859 |
SBP (mm Hg) | 147.84 +/- 11.33 | 141 +/- 11.88 | 0.039 |
DBP (mm Hg) | 85.24 +/-5.98 | 81.47 +/- 7.29 | 0.043 |
FBS (mg%) | 144.05 +/- 81.59 | 142.94 +/- 70.42 | 0.959 |
PPBS (mg%) | 229.17 +/- 112.52 | 208.15 +/- 60.97 | 0.436 |
Urea | 37.82 +/- 17.0 | 34.52 +/- 19.0 | 0.509 |
Creatinine | 1.41 +/- 0.74 | 1.07 +/- 0.331 | 0.053 |
Hemoglobin (g%) | 10.71 +/- 2.36 | 11.77 +/- 2.44 | 0.118 |